Tag: protocol
Top News
HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review
HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.
- Our Sponsors Ad -